Long-term follow-up of jaw osteomyelitis associated with bisphosphonate use in a tertiary-care center

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue 1, 2014, Pages 18-22

  Pigrau Serrallach, Carlos ^a,b   Cabral Galeano, Evelyn ^a,b   Almirante Gragera, Benito ^a,b   Sordé Masip, Roger ^a,b   Rodriguez Pardo, Dolors ^a,b   Fernandez Hidalgo, Nuria ^a,b   Larrosa Escartín, Nieves ^a,b   Bescos Atín, Socorro ^a   Pahissa Berga, Albert ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Department of Internal Medicine   (Spain)

Author keywords

Bisphosphonate related jaw osteomyelitis; Bisphosphonate related osteonecrosis; Bisphosphonates; Jaw osteomyelitis; Jaw osteonecrosis

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM; CLINDAMYCIN; COTRIMOXAZOLE; ERTAPENEM; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN DERIVATIVE; RIFAMPICIN; BONE DENSITY CONSERVATION AGENT;

ACTINOMYCES; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL FEATURE; DEBRIDEMENT; DRUG USE; FOLLOW UP; HUMAN; JAW OSTEOMYELITIS; MEDICAL RECORD REVIEW; OSTEOMYELITIS; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; ACTINOMYCOSIS; ADULT; AGED; ANTIBIOTIC SENSITIVITY; BONE NECROSIS; BONE SWELLING; CONTROLLED STUDY; DRUG EXPOSURE; DRUG TREATMENT FAILURE; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; HYPERBARIC OXYGEN; INCIDENCE; JAW DISEASE; JAW PAIN; MALE; NONHUMAN; ORAL PARESTHESIA; ORTHOPEDIC SURGERY; RELAPSE; SEQUESTRECTOMY; TERTIARY CARE CENTER; TOOTH INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; CHEMICALLY INDUCED; JAW; MICROBIOLOGY; MIDDLE AGED; TIME;

AGED; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAW; MALE; MIDDLE AGED; OSTEOMYELITIS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TIME FACTORS;

EID: 84892622236     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.01.007     Document Type: Article

References (26)

1. C.A. Migliorati, M.M. Schubert, D.E. Peterson, and L.M. Seneda Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy Cancer 104 2005 83 93
2. A.O. Hoff, B.B. Toth, K. Altundag, M.M. Johnson, C.L. Warneke, and M. Hu et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 2008 826 836
3. S.L. Silverman, and R. Landesberg Osteonecrosis of the jaw and the role of bisphosphonates: a critical review Am J Med 122 Suppl. 2009 S33 S45
4. S.L. Ruggiero, and B. Mehrotra Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management Annu Rev Med 60 2009 85 96
5. S.B. Woo, J.W. Hellstein, and J.R. Kalmar Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 2006 753 761
6. R.E. Marx, Y. Sawatari, M. Fortin, and V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567 1575
7. A. Badros, D. Weikel, A. Salama, O. Goloubeva, A. Schneider, and A. Rapoport et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors J Clin Oncol 24 2006 945 952
8. J.C. Lo, F.S. O'Ryan, N.P. Gordon, J. Yang, R.L. Hui, and D. Martin et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure J Oral Maxillofac Surg 68 2010 243 253
9. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
10. S. Pozzi, R. Marcheselli, S. Sacchi, L. Baldini, F. Angrilli, and E. Pennese et al. Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients Leuk Lymphoma 48 2007 56 64
11. S. Khosla, D. Burr, J. Cauley, D.W. Dempster, P.R. Ebeling, and D. Felsenberg et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479 1491
12. C. Pigrau, B. Almirante, D. Rodriguez, N. Larrosa, S. Bescos, and G. Raspall et al. Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure Eur J Clin Microbiol Infect Dis 28 2009 317 323
13. American Academy of Oral and Maxillofacial Surgeons. Position paper on bisphosphonates-related osteonecrosis of the Jaws. Available at: http://www. Aaoms.org/docs/position-papers/osteonecrosis.pdf (accessed 11.12.06).
14. J. Wood, K. Bonjean, S. Ruetz, A. Bellahcene, L. Devy, and J.M. Foidart et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Pharmacol Exp Ther 302 2002 1055 1061
15. J.B. Aragon-Ching, Y.M. Ning, C.C. Chen, L. Latham, J.P. Guadagnini, and J.L. Gulley et al. Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents Cancer Invest 27 2009 221 226
16. Chapter 255 T. Russo Agents of actinomycosis G. Mandell, J. Bennett, R. Dolin, Principles and practice of infectious diseases 7th ed. 2010 Churchill/Elsevier Livingstone/Philadelphia 3209 3219 [Elsevier 2010]
17. T. Hansen, M. Kunkel, E. Springer, C. Walter, A. Weber, and E. Siegel et al. Actinomycosis of the jaws - histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis Virchows Arch 451 2007 1009 1017
18. N.H. Naik, and T.A. Russo Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces Clin Infect Dis 49 2009 1729 1732
19. P.P. Sedghizadeh, S.K. Kumar, A. Gorur, C. Schaudinn, C.F. Shuler, and J.W. Costerton Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of jaw secondary to bisphosphonate therapy J Ala Dent Assoc 140 2009 1259 1265
20. J.A. Arranz, E. Flores, S. Ngo, V. lopez, J.L. Dominguez, and A. restoy Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces Med Clin 2012 http://dx.doi.org/10.1016/j.medcli.2012.05.039
21. M.H. Abu-Id, P.H. Warnke, J. Gottschalk, I. Springer, J. Wiltfang, and Y. Acil et al. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw J Craniomaxillofac Surg 36 2008 95 103
22. O. Nicolatou-Galitis, E. Papadopoulou, T. Sarri, P. Boziari, A. Karayianni, and M.C. Kyrtsonis et al. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 195 202
23. T.S. Lazarovici, R. Yahalom, S. Taicher, S. Elad, I. Hardan, and N. Yarom Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients J Oral Maxillofac Surg 67 2009 850 855
24. C.A. Migliorati, J. Casiglia, J. Epstein, P.L. Jacobsen, M.A. Siegel, and S.B. Woo Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper J Am Dent Assoc 136 2005 1658 1668
25. T. Mücke, J. Kochschinski, H. Deppe, S. Wagenpfeil, C. Pautke, and D.A. Mitchell et al. Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaw J Cancer Res Clin Oncol 137 2001 907 913
26. M.T. Petrucci, C. Gallucci, A. Agrillo, M.C. Mustazza, and R. Foa Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients Haematologica 92 2007 1289 1290